Aqr Capital Management LLC Castle Biosciences Inc Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $155,171 - $217,377	8,592 Added 60.49%	22,795 $504,000
Q4 2023 Feb 14, 2024	SELL	$12.19 - $22.43 $2,925 - $5,383	-240 Reduced 1.66%	14,203 $306,000
Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $191,803 - $293,192	14,443 New	14,443 $243,000
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $319,496 - $489,933	-6,381 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $261,958 - $432,729	-4,446 Reduced 41.06%	6,381 $437,000
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $472,057 - $790,912	10,827 New	10,827 $727,000

171

25.5M

511K

130K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $733M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.